1. Home
  2. ATYR vs BRBS Comparison

ATYR vs BRBS Comparison

Compare ATYR & BRBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • BRBS
  • Stock Information
  • Founded
  • ATYR 2005
  • BRBS 1893
  • Country
  • ATYR United States
  • BRBS United States
  • Employees
  • ATYR 59
  • BRBS N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • BRBS Commercial Banks
  • Sector
  • ATYR Health Care
  • BRBS Finance
  • Exchange
  • ATYR Nasdaq
  • BRBS Nasdaq
  • Market Cap
  • ATYR 327.0M
  • BRBS 274.5M
  • IPO Year
  • ATYR 2015
  • BRBS N/A
  • Fundamental
  • Price
  • ATYR $3.86
  • BRBS $3.32
  • Analyst Decision
  • ATYR Strong Buy
  • BRBS
  • Analyst Count
  • ATYR 6
  • BRBS 0
  • Target Price
  • ATYR $18.60
  • BRBS N/A
  • AVG Volume (30 Days)
  • ATYR 1.9M
  • BRBS 235.8K
  • Earning Date
  • ATYR 03-13-2025
  • BRBS 04-29-2025
  • Dividend Yield
  • ATYR N/A
  • BRBS N/A
  • EPS Growth
  • ATYR N/A
  • BRBS N/A
  • EPS
  • ATYR N/A
  • BRBS N/A
  • Revenue
  • ATYR $235,000.00
  • BRBS $97,334,000.00
  • Revenue This Year
  • ATYR $1,387.23
  • BRBS N/A
  • Revenue Next Year
  • ATYR $873.22
  • BRBS N/A
  • P/E Ratio
  • ATYR N/A
  • BRBS N/A
  • Revenue Growth
  • ATYR N/A
  • BRBS N/A
  • 52 Week Low
  • ATYR $1.42
  • BRBS $2.45
  • 52 Week High
  • ATYR $4.66
  • BRBS $3.83
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 50.20
  • BRBS 42.49
  • Support Level
  • ATYR $2.98
  • BRBS $3.24
  • Resistance Level
  • ATYR $4.32
  • BRBS $3.38
  • Average True Range (ATR)
  • ATYR 0.36
  • BRBS 0.09
  • MACD
  • ATYR 0.03
  • BRBS -0.01
  • Stochastic Oscillator
  • ATYR 60.37
  • BRBS 27.38

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About BRBS Blue Ridge Bankshares Inc.

Blue Ridge Bankshares Inc is a United States-based company engaged in offering commercial and consumer banking and financial services through its wholly-owned bank subsidiary, Blue Ridge Bank, National Association, and its non-bank financial services affiliates. The bank offers services such as checking accounts, savings accounts, money market accounts, cash management accounts, commercial and industrial loans, residential mortgages, commercial mortgages, home equity loans, consumer installment loans, investment accounts, insurance and others. It has three reportable business segments: commercial banking, mortgage banking, and holding company activities.

Share on Social Networks: